Clonogenic Analysis Reveals Reserve Stem Cells in Postnatal Mammals. II. Pluripotent Epiblastic-Like Stem Cells

Anatomical Record - Part A Discoveries in Molecular, Cellular, and Evolutionary Biology

Volumn 277, Issue 1, 2004, Pages 178-203

  Young, Henry E ^a   Duplaa, Cecile ^b   Yost, Michael J ^c   Henson, Nicholas L ^a   Floyd, Julie A ^a   Detmer, Kristina ^a   Thompson, Angela J ^a   Powell, Steven W ^a   Gamblin, T Clark ^a   Kizziah, Kirk ^a   Holland, Benjamin J ^a   Boev, Angel ^a   Van De Water, J M ^a   Godbee, Dan C ^d   Jackson, Stephanie ^e   Rimando, Marylen ^e   Edwards, Chad R ^a   Wu, Eveline ^a   Cawley, Chris ^a   Edwards, Pamela D ^a   Macgregor, Anna ^a   Bozof, Ryan ^a   Thompson, T Michele ^f   Petro Jr , George J ^a   Shelton, Heather M ^a   McCampbell, Beth L ^a   Mills, Jared C ^a   Flynt, Frederick L ^a   Steele, Timothy A ^g   Kearney, Marianne ^h   Kirincich Greathead, Amy ^c   Hardy, Wade ^a   Young, Paul R ^a   Amin, Aman V ^a   Williams, R Steve ^a   Horton, Miranda M ^a   McGuinn, Shaun ^a   Hawkins, Kristina C ^a   Ericson, Kurt ^c   Terracio, Louis ⁱ   Moreau, Catherine ^b   Hixson, Douglas ^j   Tobin, Brian W ^a   Hudson, John ^a   Bowyer III, Frank P ^a   Black Jr , Asa C ^a   more..

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSERM   (France)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e MERCER UNIVERSITY   (United States)

^f Mountain Area Health Education Center   (United States)

^g DES MOINES UNIVERSITY   (United States)

^h ST ELIZABETH'S MEDICAL CENTER   (United States)

ⁱ NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^j BROWN UNIVERSITY   (United States)

more..

Author keywords

Diabetes; Gene therapy; Myocardial infarction; Pluripotent stem cells

Indexed keywords

INSULIN; TELOMERASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLASTOCYST; CELL CLONE; CELL DIFFERENTIATION; CELL NUCLEUS; CLONOGENESIS; CONTROLLED STUDY; CYTOPLASM; DIABETES MELLITUS; ECTODERM; EMBRYO CELL; ENDODERM; GENE THERAPY; HEART INFARCTION; INNER CELL MASS; MAMMAL; MESODERM; MOUSE; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; PLURIPOTENT STEM CELL; PRIMATE; PRIORITY JOURNAL; RODENT; SKELETAL MUSCLE; TERATOMA; TISSUE ENGINEERING;

MAMMALIA; PRIMATES; RODENTIA;

EID: 10744226582     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ar.a.20000     Document Type: Article

References (135)

1. Alvarez-Buylla A, Buskirk DR, Nottebohm F. 1987. Monoclonal antibody reveals radial glia in adult avian brain. J Comp Neurol 264: 159-170.
2. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA. 2000. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227:271-278.
3. Asher RA, Scheibe RJ, Keiser HD, Bignami A. 1995. On the existence of a cartilage-like proteoglycan and link proteins in the central nervous system. Glia 13:294-308.
4. Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M. 2001. Insulin production by human embryonic stem cells. Diabetes 50:1691-1697.
5. August JT, Hildreth JEK. 2002. H5A4 for CD11b (Mac-1, CR3), H5H5 for CD43 (human) sialophorin, H4C4 for CD44 human hyaluronate receptor, H5A5 for CD45 (lymphocyte common antigen) (human), H5C6 for CD63 (human) LIMP. 2002. In: Developmental studies hybridoma bank product catalogue, year 2002. Iowa City, IA: University of Iowa. p 11.
6. Bader D, Masaki T, Fischman DA. 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J Cell Biol 95:763-770.
7. Banerjee A, Roach MC, Wall KA, Lopata MA, Cleveland DW, Luduena RF. 1988. A monoclonal antibody against the type II isotype of beta-tubulin. Preparation of isotypically altered tubulin. J Biol Chem 263:3029-3034.
8. Banerjee A, Roach MC, Trcka P, Luduena RF. 1990. Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of beta-tubulin. J Biol Chem 265:1794-1799.
9. Baudier J, Glasser N, Gerard D. 1986. Ions binding to S100 proteins. I. Calcium- and zinc-binding properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn2+ regulates Ca2+ binding on S100b protein. J Biol Chem 261:8192-8203.
10. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song K-H, Sharma A, O'Neil JJ. 2000. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 97:7999-8004.
11. Brehm A, Ovitt CE, Scholer HR. 1998. Oct-4: more than just a POUerful marker of mammalian germline? APMIS 106:114-126.
12. Burgeson RE, Hollister DW. 1979. Collagen heterogeneity in human cartilage: identification of several new collagen chains. Biochem Biophys Res Commun 87:1124-1131.
13. Butcher EC. 2002. Hermes-1 for CD44. In: Developmental studies hybridoma bank product catalog, year 2002, NICHHD. Iowa City, IA: University of Iowa. p 12.
14. Campisi J. 1997. The biology of replicative senescence. Cancer 33: 703-709.
15. Caterson B, Baker JR, Christner JE, Lee Y, Lentz M. 1985. Monoclonal antibodies as probes for determining the microheterogeneity of the link proteins of cartilage proteoglycan. J Biol Chem 260:11348-11356.
16. Caterson B. 2002. 9/30/8-A-4 for link protein, 12/21/1-C-6 for proteoglycan hyaluronic acid binding region. In: Developmental studies hybridoma bank product catalog, year 2002, NICHHD. Iowa City, IA: University of Iowa. p 13.
17. Cheng L, Hammond H, Ye Z, Zhan X, Dravid G. 2003. Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells 21:131-142.
18. Couffinhal T, Kearne M, Sullivan A, Silver M, Tsurumi Y, Isner JM. 1997. Histochemical staining following LacZ gene transfer underestimates transfection efficiency. Hum Gene Ther 8:929-934.
19. Damjanov I, Fox N, Knowles BB, Solter D, Lange BH, Fraley EE. 1982. Immunohistochemical localization of murine stage specific embryonic antigens in human testicular germ cell tumors. Am J Pathol 108:225-230.
20. Debus E, Weber K, Osborn M. 1983. Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides. Differentiation 25:193-203.
21. Detn CL, Latchman DS. 1993. In: Latchman DS, editor. Transcription factors: a practical approach. New York: Oxford University Press. p 1-26.
22. Dittel BN, McCarthy JB, Wayner EA, LeBien TW. 1993. Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood 81:2272-2282.
23. Drazba J, Pierce M, Lemmon V. 1991. Studies of the developing chick retina using monoclonal antibody 8A2 that recognizes a novel set of gangliosides. Dev Biol 145:154-163.
24. Eisenberg CA, Markwald RR. 1997. Mixed cultures of avian blastoderm cells and the quail mesoderm cell line QCE-6 provide evidence for the pluripotentiality of early mesoderm. Dev Biol 191:167-181.
25. Eisenberg CA, Gourdie RG, Eisenberg LM. 1997. Wnt-11 is expressed in early avian mesoderm and required for the differentiation of the quail mesoderm cell line QCE-6. Development 124:525-536.
26. Estrera VT, Luo W, Phan D, Earley K, Hixson DC. 1999. The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells. Biochem Biophys Res Commun 263:797-803.
27. Evans MJ, Kaufman M. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156.
28. Faris RA, McEntire KD, Thompson NL, Hixson DC. 1990. Identification and characterization of a rat hepatic oncofetal membrane glycoprotein. Cancer Res 50:4755-4763.
29. Faris RA, Monfils BA, Dunsford HA, Hixson DC. 1991. Antigenic relationship between oval cells and a subpopulation of hepatic foci, nodules and carcinomas induced by the 'resistant hepatocyte' model system. Cancer Res 51:1308-1317.
30. Feany MB, Lee S, Edwards RH, Buckley KM. 1992. The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell 70:861-867.
31. Franke FE, Schachenmayr W, Osborn M, Altmannsberger M. 1991. Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors. Am J Pathol 139:67-79.
32. Frid MG, Shekhonin BV, Koteliansky VE, Glukhova MA. 1992. Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. Dev Biol 153:185-193.
33. Friedman B, Hockfield S, Black JA, Woodruff KA, Waxman SG. 1989. In situ demonstration of mature oligodendrocytes and their processes: an immunocytochemical study with a new monoclonal antibody, rip. Glia 2:380-390.
34. Gordon GJ, Coleman WB, Hixson DC, Grisham JW. 2000. Liver regeneration in rats with retrorsine-induced hepatocellular injury proceeds through a novel cellular response. Am J Pathol 156:607-619.
35. Gorski JP, Griffin D, Dudley G, Stanford C, Thomas R, Huang C, Lai E, Karr B, Solursh M. 1990. Bone acidic glycoprotein-75 is a major synthetic product of osteoblastic cells and localized as 75- and/or 50-kDa forms in mineralized phases of bone and growth plate and in serum. J Biol Chem 265:14956-14963.
36. Gritti A, Parati EA, Cova L, Frolichsthal P, Galli R, Wanke E, Faravelli L, Morassutti DJ, Roisen F, Nickel DD, Vescovi AL. 1996. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci 16:1091-1100.
37. Harley CB, Futcher AB, Greider CW. 1990. Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460.
38. Hayflick L, Moorehead PS. 1961. The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621.
39. Hayflick L. 1963. Human diploid cell strains as hosts for viruses. Perspect Virol 3:213-237.
40. Hayflick L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37:614-636.
41. Henderson JK, Draper JS, Baillie HS, Fishel S, Thomson JA, Moore H, Andrews PW. 2002. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 20:329-337.
42. Hildreth JE, August JT. 1985. The human lymphocyte function-associated (HLFA) antigen and a related macrophage differentiation antigen (HMac-1): functional effects of subunit-specific monoclonal antibodies. J Immunol 134:3272-3280.
43. Hixson DC, Ponce MDL, Allison JP, Walborg Jr EF. 1984. Cell surface expression by adult rat hepatocytes of a non-collagen glycoprotein present in rat liver biomatrix. Exp Cell Res 152:402-414.
44. Hixson DC, Faris RA, Thompson NL. 1990. An antigenic portrait of the liver during carcinogenesis. Pathobiology 58:65-77.
45. Hixson DC, Brown J, McBride A, Affigne S. 2000. Differentiation status of rat ductal cells and ethionine-induced hepatic carcinomas defined with surface-reactive monoclonal antibodies. Exp Mol Pathol 68:152-169.
46. Hockfield S, McKay RD. 1985. Identification of major cell classes in the developing mammalian nervous system. J Neurosci 5:3310-3328.
47. Holmdahl R, Rubin K, Klareskog L, Larsson E, Wigzell H. 1986. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum 29:400-410.
48. Hubbard AL, Bartles JR, Braiterman LT. 1985. Identification of rat hepatocyte plasma membrane proteins using monoclonal antibodies. J Cell Biol 100:1115-1125.
49. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM. 2002a. Multipotent progenitor cells can be isolated from bone marrow, muscle and brain. Exp Hematol 30:896-904.
50. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. 2002b. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:25-27.
51. Joshi HC, Cleveland DW. 1990. Diversity among tubulin subunits: toward what functional end? Cell Motil Cytoskel 16:159.
52. Kasugai S, Nagata T, Sodek J. 1992. Temporal studies on the tissue compartmentalization of bone sialoprotein (BSP), osteopontin (OPN), and SPARC protein during bone formation in vitro. J Cell Physiol 152:467-477.
53. Kishimoto T, Kikutani H, von dem Borne AEGK, Goyert SM, Mason D, Miyasaka M, Moretta L, Okumura K, Shaw S, Springer T, Sugamura K, Zola H. 1997. Leucocyte typing VI, white cell differentiation antigens. Hamden, CT: Garland Publishing.
54. Kumagai J, Sarkar K, Uhthoff HK, Okawara Y, Ooshima A. 1994. Immunohistochemical distribution of type I, II and III collagens in the rabbit supraspinatus tendon insertion. J Anat 185:279-284.
55. Lannagi R, Cochran NA, Ishigami F, Hakomori S-I, Andrews PW, Knowles BB, Solter D. 1983. Stage specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human treatocarcinoma cells. EMBO J 2:2355-2361.
56. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. 1993. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 90:999-1003.
57. Lenardo MJ, Staudt L, Robbins P, Kuang A, Mulligan RC, Baltimore D. 1989. Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor. Science 243:544-546.
58. Lewinsohn DM, Nagler A, Ginzton N, Greenberg P, Butcher EC. 1990. Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood 75:589-595.
59. Lin H, Lei JQ, Wininger D, Nguyen M-T, Khanna R, Hartmann C, Yan W-L, Huang SG. 2003. Multilineage potential of homozygous stem cells derived from metaphase II oocytes. Stem Cells 21:152-161.
60. Liu JP. 2000. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J 13:2091-2104.
61. Lucas PA, Calcutt AF, Ossi P, Young HE, Southerland SS. 1993. Mesenchymal stem cells from granulation tissue. J Cell Biochem 17E:122.
62. Lucas PA, Calcutt AF, Southerland SS, Warejcka D, Young HE. 1995. A population of cells resident within embryonic and newborn rat skeletal muscle is capable of differentiating into multiple mesodermal phenotypes. Wound Rep Reg 3:457-468.
63. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. 2001. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389-1393.
64. Martin GM, Sprague CA, Epstein CJ. 1970. Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab Invest 23:86-92.
65. Martin GR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78:7634-7638.
66. Morhenn VB. 2002. VM-1 for keratinocyte, basal, cell attachment antigen (human). In: Developmental studies hybridoma bank product catalog, year 2002, NICHHD. Iowa City, IA: University of Iowa. p 24.
67. Mujoo K, Ali M, Sahib MK. 1983. Isolation, characterization, and synthesis of alpha-fetoprotein from neonatal rat brain. J Neurochem 41:1223-1228.
68. Naumann K, Pette D. 1994. Effects of chronic stimulation with different impulse patterns on the expression of myosin isoforms in rat myotube cultures. Differentiation 55:203-211.
69. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct-4. Cell 95:379-391.
70. Niwa H, Miyazaki J-I, Smith AG. 2000. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376.
71. Niwa H, Masui S, Chambers I, Smith AG, Miyazaki J-I. 2002. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol Cell Biol 22:1526-1536.
72. Oseroff AR, Pfendt EA, DiCicco L, Morhenn VB. 1985. A murine monoclonal antibody (VM-1) against human basal cells inhibits the growth of human keratinocytes in culture. J Invest Dermatol 84: 257-261.
73. Palmieri SL, Peter W, Hess H, Scholer HR. 1994. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in transplantation. Dev Biol 166:259-267.
74. Pate DW, Southerland SS, Grande DA, Young HE, Lucas PA. 1993. Isolation and differentiation of mesenchymal stem cells from rabbit muscle. Surg Forum XLIV:587-589.
75. Pera MF, Reubinoff B, Trounson A. 2000. Human embryonic stem cells. J Cell Sci 113:5-10.
76. Pesce M, Scholer HR. 2000. Oct-4: control of totipotency and germline determination. Mol Reprod Dev 55:452-457.
77. Pesce M, Scholer HR. 2001. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19:271-278.
78. Picker LJ, Nakache M, Butcher EC. 1989. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 109:927-937.
79. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
80. Price RL, Chintanowonges C, Shiraishi I, Borg TK, Terracio L. 1996. Local and regional variations in myofibrillar patterns in looping rat hearts. Anat Rec 245:83.
81. Rajagopal J, Anderson WJ, Kume S, Martinez OI, Melton DA. 2003. Insulin staining of ES cell progeny from insulin uptake. Science 299:363.
82. Reubinoff BE, Pera MF, Fong C-Y, Trounson A, Bongso A. 2000. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399-404.
83. Reyes M, Verfaillie CM. 2001. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann NY Acad Sci 938:231-233; discussion, 233-235.
84. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. 2002. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109:337-346.
85. Reynolds R, Carey EM, Herschkowitz N. 1989. Immunohistochemical localization of myelin basic protein and 2′,3′-cyclicnucleotide 3′-phosphohydrolase in flattened membrane expansions produced by cultured oligodendrocytes. Neuroscience 28:181-188.
86. Rhome D. 1981. Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci USA 78:5009-5013.
87. Rogers JJ, Adkison LR, Black Jr AC, Lucas PA, Young HE. 1995. Differentiation factors induce expression of muscle, fat, cartilage, and bone in a clone of mouse pluripotent mesenchymal stem cells. Am Surg 61:1-6.
88. Romero-Ramos M, Vourc'h P, Young HE, Lucas PA, Wu Y, Chivatakarn O, Zaman R, Dunkelman N, El-Kalay MA, Chesselet M-F. 2002. Neuronal differentiation of stem cells isolated from adult muscle. J Neurosci Res 69:894-907.
89. Ronnov-Jessen L, Celis JE, Van Deurs B, Petersen OW. 1992. A fibroblast-associated antigen: characterization in fibroblasts and immunoreactivity in smooth muscle differentiated stromal cells. J Histochem Cytochem 40:475-486.
90. Schaart G, Moens L, Endert JM. Ramaekers FCS. 1997. Biochemical characterization of cardiotin, a sarcoplasmic reticulum associated protein. FEBS Lett 403:168-172.
91. Schneider EL, Mitsui Y. 1976. The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci USA 73:3584-3588.
92. Scholer HR, Hatzopoulos AK, Baling R, Suzuki N, Gruss P. 1989. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J 8:2543-2550.
93. Scholer HR, Dressler GR, Baling R, Rohdewohld H, Gruss P. 1990. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J 9:2185-2195.
94. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, Lenvik T, Johnson S, Hu WS, Verfaillie CM. 2002. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109:1291-1302.
95. Shafiq SA, Shimizu T, Fischman DA. 1984. Heterogeneity of type I skeletal muscle fibers revealed by monoclonal antibody to slow myosin. Muscle Nerve 7:380-387.
96. Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, Blumenthal PD, Huggins GR, Gearhart JD. 1998. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 95:13726-13731.
97. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. 1986. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 103:2787-2796.
98. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. 1997. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337:1584-1590.
99. Solter D, Knowles BB. 1978. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 75:5565-5569.
100. Sprinkle TJ, Agee JF, Tippins RB, Chamberlain CR, Faguet GB, DeVries GH. 1987. Monoclonal antibody production to human and bovine 2′:3′ -cyclic nucleotide 3′ ′-phosphodiesterase (CNPase): high-specificity recognition in whole brain acetone powders and conservation of sequence between CNP1 and CNP2. Brain Res 426:349-357.
101. Sprinkle T. 1989. 2′,3′-cyclic nucleotide 3′-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. CRC Crit Rev Neurobiol 4:235-301.
102. St. Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW. 2000. Genes expressed in human tumor endothelium. Science 289:1197-1202.
103. Thomson JA, Kalishman J, Golos TG, Durning M, Harris CP, Becker RA, Hearn JP. 1995. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci USA 92:7844-7848.
104. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
105. Thulasi R, Dias P, Houghton PJ, Houghton JA. 1996. Alpha 2a-interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type I receptor. Cell Growth Differ 7:531-541.
106. Tole S, Patterson PH. 1995. Regionalization of the developing forebrain: a comparison of FORSE-1, Dlx-2, and BF-1. J Neurosci 15:970-980.
107. Tole S, Kaprielian Z, Ou SK, Patterson PH. 1995. FORSE-1: a positionally regulated epitope in the developing rat central nervous system. J Neurosci 15:957-969.
108. Vaziri H, Benchimol S. 1996. From telomere loss to p53 induction and activation of a DNA damage pathway at senescence: the telomere loss/DNA damage model of cell aging. Exp Gerontol 31:295-301.
109. Walborg Jr EF, Tsuchida S, Weeden DS, Thomas MW, Barrick A, McEntire KD, Allison JP, Hixson DC. 1985. Identification of dipeptidyl peptidase IV as a protein shared by the plasma membrane of hepatocytes and liver biomatrix. Exp Cell Res 158:509-518.
110. Warejcka DJ, Harvey R, Taylor BJ, Young HE, Lucas PA. 1996. A population of cells isolated from rat heart capable of differentiating into several mesodermal phenotypes. J Surg Res 62:233-242.
111. Watkitani S, Takaoka K, Hattori T, Miyazawa N, Iwanaga T, Takeda S, Watanabe TK, Tanigami A. 2003. Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint. Rheumatology 42:162-165.
112. Webster C, Silberstein L, Hays AP, Blau HM. 1988. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52:503-513.
113. Weksler B, Ng B, Lenert J, Burt M. 1994. A simplified method for endotracheal intubation in the rat. J Appl Physiol 76:1823-1825.
114. Wood JN, Anderton BH. 1981. Monoclonal antibodies to mammalian neurofilaments. Biosci Rep 1:263-268.
115. Wright WE, Binder M, Funk W. 1991. Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol Cell Biol 11:4104-4110.
116. Ye XJ, Terato K, Nakatani H, Cremer MA, Yoo TJ. 1991. Monoclonal antibodies against bovine type IX collagen (LMW fragment): production, characterization, and use for immunohistochemical localization studies. J Histochem Cytochem 39:265-271.
117. Yeom Y, Fuhrmann G, Ovitt CE, Brehm A, Ohbo K, Gross M, Hubner K, Scholer HR. 1996. Germline regulatory element Oct-4 specific for the totipotent cycle of embryonal cells. Development 122:881-894.
118. Young HE, Dalley BK, Markwald RR. 1989a . Glycoconjugates in normal wound tissue matrices during the initiation phase of limb regeneration in adult Ambystoma. Anat Rec 223:231-241.
119. Young HE, Dalley BK, Markwald RR. 1989b. Effect of selected denervations on glycoconjugate composition and tissue morphology during the initiation phase of limb regeneration in adult Ambystoma. Anat Rec 223:223-230.
120. Young HE, Carrino DA, Caplan AI. 1989c. Histochemical analysis of newly synthesized and resident sulfated glycosaminoglycans during musculogenesis in the embryonic chick leg. J Morph 201:85-103.
121. Young HE, Morrison DC, Martin JD, Lucas PA. 1991. Cryopreservation of embryonic chick myogenic lineage-committed stem cells. J Tiss Cult Meth 13:275-284.
122. Young HE, Ceballos EM, Smith JC, Lucas PA, Morrison DC. 1992a. Isolation of embryonic chick myosatellite and pluripotent stem cells. J Tiss Cult Meth 14:85-92.
123. Young HE, Sippel J, Putnam LS, Lucas PA, Morrison DC. 1992b. Enzyme-linked immuno-culture assay. J Tiss Cult Meth 14:31-36.
124. Young HE, Ceballos EM, Smith JC, Mancini ML, Wright RP, Ragan BL, Bushell I, Lucas PA. 1993. Pluripotent mesenchymal stem cells reside within avian connective tissue matrices. In Vitro Cell Dev Biol 29A:723-736.
125. Young HE, Mancini ML, Wright RP, Smith JC, Black Jr AC, Reagan CR, Lucas PA. 1995. Mesenchymal stem cells reside within the connective tissues of many organs. Dev Dyn 202:137-144.
126. Young HE, Wright RP, Mancini ML, Lucas PA, Reagan CR, Black Jr AC. 1998a. Bioactive factors affect proliferation and phenotypic expression in pluripotent and progenitor mesenchymal stem cells. Wound Rep Reg 6:65-75.
127. Young HE, Rogers JJ, Adkison LR, Lucas PA, Black Jr AC. 1998b. Muscle morphognetic protein induces myogenic gene expression in Swiss-3T3 cells. Wound Rep Reg 6:530-541.
128. Young HE, Steele TA, Bray RA, Detmer K, Blake LW, Lucas PA, Black Jr AC. 1999. Human pluripotent and progenitor cells display cell surface cluster differentiation markers CD10, CD13, CD56, and MHC Class-I. Proc Soc Exp Biol Med 221:63-71.
129. Young HE. 2000. Stem cells and tissue engineering. In: Huard J, Fu FH, editors. Gene therapy in orthopaedic and sports medicine. New York: Springer-Verlag. p 143-173.
130. Young HE, Duplaa C, Young TM, Floyd JA, Reeves ML, Davis KH, Mancini GJ, Eaton ME, Hill JD, Thomas K, Austin T, Edwards C, Cuzzourt J, Parikh A, Groom J, Hudson J, Black Jr AC. 2001a. Clonogenic analysis reveals reserve stem cells in postnatal mammals. I. Pluripotent mesenchymal stem cells. Anat Rec 263:350-360.
131. Young HE, Steele T, Bray RA, Hudson J, Floyd JA, Hawkins KC, Thomas K, Austin T, Edwards C, Cuzzourt J, Duenzl M, Lucas PA, Black Jr AC. 2001b. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 264:51-62.
132. Young HE. 2004. Existence of reserve quiescent stem cells in adults, from amphibians to humans. Curr Top Microbiol Immunol 280:71-109.
133. Young HE, Black Jr AC. 2003. Adult stem cells. Anat Rec 276A:75-102.
134. Young HE, Duplaa C, Romero-Ramos M, Chessellet M-F, Vourc'h P, Yost MJ, Ericson K, Terracio L, Asahara T, Masuda H, Tamura-Ninomiya S, Detmer K, Bray RA, Steele TA, Hixson D, El-Kalay M, Tobin BW, Russ RD, Horst MN, Floyd JA, Henson NL, Hawkins KC, Groom J, Blake L, Bland LJ, Thompson AJ, Kirincich A, Moreau C, Hudson J, Bowyer III FP, Lin T-J, Black Jr AC. 2004. Adult reserve stem cells and their potential for tissue engineering. Cell Biochem Biophys 40 (in press).
135. Zhao Y, Glesne D, Huberman E. 2003. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 100:2426-2431.